Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Functionalisation of MSN with mannose for PDT applications dramatically improved the efficiency of PDT on breast cancer cells.
Brevet
David
D
Institut Charles Gerhardt Montpellier UMR 5253 CNRS-UM2-ENSCM-UM1, laboratoire CMOS, CC 1701, Place Eugène Bataillon, 34095 Montpellier cedex 05, France.
Gary-Bobo
Magali
M
Raehm
Laurence
L
Richeter
Sébastien
S
Hocine
Ouahiba
O
Amro
Kassem
K
Loock
Bernard
B
Couleaud
Pierre
P
Frochot
Céline
C
Morère
Alain
A
Maillard
Philippe
P
Garcia
Marcel
M
Durand
Jean-Olivier
JO
D017209:Apoptosis; D045744:Cell Line, Tumor; D016503:Drug Delivery Systems; D006367:HeLa Cells; D006801:Humans; D037181:Lectins, C-Type / Q000378:metabolism; D008358:Mannose / Q000737:chemistry* / Q000378:metabolism; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins / Q000378:metabolism; D015394:Molecular Structure; D053758:Nanoparticles / Q000737:chemistry*; D010778:Photochemotherapy; D011956:Receptors, Cell Surface / Q000378:metabolism; D012822:Silicon Dioxide / Q000737:chemistry*
D037181:Lectins, C-Type; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D011956:Receptors, Cell Surface; D012822:Silicon Dioxide; D008358:Mannose